Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Total Non-Current Liabilities: 2018

Historic Total Non-Current Liabilities for Dianthus Therapeutics (DNTH) over the last 1 years, with Dec 2018 value amounting to $1.2 million.

  • Dianthus Therapeutics' Total Non-Current Liabilities was N/A to $1.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2018, which is N/A change from last year.
  • Dianthus Therapeutics' Total Non-Current Liabilities amounted to $1.2 million in FY2018.
  • In the past 5 years, Dianthus Therapeutics' Total Non-Current Liabilities ranged from a high of $1.2 million in FY2018 and a low of $1.2 million during FY2018.
  • Over the past 1 years, Dianthus Therapeutics' median Total Non-Current Liabilities value was $1.2 million (recorded in 2018), while the average stood at $1.2 million.